SA’s regulators are struggling to keep up with black market weight-loss jabs

AI justification

Regulatory failure to curb black-market drugs outweighs isolated court victory, harming public health. | The court ruling represents a positive step in upholding pharmaceutical safety and regulatory authority, aligning with public health goals (SDG 3) and justice (SDG 16). However, the persistent black market and delayed regulatory reforms undermine these gains, creating a net negative impact on health rights and systemic trust.